🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
A study evaluating efficacy and safety of repeated doses of PT027 compared ...
Status
Completed
Location
Research Site
Start Date
2022-09-28
Trial ID
NCT05555290
This is a randomized, double-blind, placebo-controlled, multicenter, parall...
Status
Completed
Location
Research Site
Start Date
2019-03-20
Trial ID
NCT03847896
Treatments Being Tested
This study is to compare the systemic exposure of budesonide delivered by t...
Status
Completed
Location
Research Site
Start Date
2019-05-16
Trial ID
NCT03934333
Treatments Being Tested
This is a Phase 1 study to compare the pharmacokinetics of budesonide and a...
Status
Completed
Location
Research Site
Start Date
2019-01-21
Trial ID
NCT03772223
The purpose of this study is to compare the effect of budesonide/albuterol ...
Status
Recruiting
Location
Research Site
Start Date
2024-05-20
Trial ID
NCT06307665
This is a randomized, double-blind, multicenter, parallel-group, variable-l...
Status
Completed
Location
Research Site
Start Date
2018-12-13
Trial ID
NCT03769090
To compare the pharmacokinetics of budesonide delivered by BDA MDI to budes...
Status
Completed
Location
IPS Research
Start Date
2021-05-06
Trial ID
NCT04848662
Treatments Being Tested
The purpose of this Phase III, multicentre, randomized, double-blind, singl...
Status
Completed
Location
Research Site
Start Date
2023-12-22
Trial ID
NCT06245551
Treatments Being Tested
ANCHOR is a prospective, phase IV, interventional, single-arm, open-label s...
Status
Active Not Recruiting
Location
Research Site
Start Date
2024-05-10
Trial ID
NCT06422689
Treatments Being Tested
An event-driven, Phase III study to evaluate the efficacy and safety of BDA...
Status
Recruiting
Location
Research Site
Start Date
2024-06-17
Trial ID
NCT06471257
Treatments Being Tested